Contact this trialFirst, we need to learn more about you.
RNAi Therapeutics
Vutrisiran for Amyloid Cardiomyopathy
Recruiting2 awardsPhase 3
Phoenix, Arizona
This trial aims to gather information on the safety and effectiveness of using vutrisiran in patients with a certain type of heart disease called ATTR amyloidosis. The study will look at patients who either
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service